General Electric Medical Systems (GEMS) is the world’s leading manufacturer of diagnostic imaging equipment and part of the Milwaukee, US-based General Electric. The following evaluation conducts a strategic analysis of its internal resource capability, how it shaped its competitive strategy and a profound evaluation of its international strategy.
Table of Contents
1. Introduction
2. GEMS Competitive Strategy
2.1 Resources Analysis
2.2 From Capabilities to Core Competences - Value Chain Analysis at General Electric Medical Systems
2.3 Cost leadership, differentiation or “hybrid” - General Electric Medical Systems Competitive Strategy drift
3. GEMS International Strategy
3.1 Evaluation of GEMS International Strategy
3.2 Has GEMS Strategy in China Transformed its Strategy from Global to a More Multidomestic Strategy?
Objectives and Key Themes
This work provides a strategic analysis of General Electric Medical Systems (GEMS), focusing on how its internal resource capabilities shape its competitive and international strategy. It examines the transition from a multidomestic approach to a more complex transnational model, evaluating the company's ability to balance global efficiency with local responsiveness in an evolving healthcare market.
- Strategic analysis of internal resource capabilities and core competencies
- Evaluation of the "Hybrid Strategy" transition to maintain competitive advantage
- Examination of the Global Value Chain and supply chain management
- Assessment of the impact of global healthcare market pressures on corporate strategy
- Analysis of the potential for the Chinese market to influence organizational structure
Excerpt from the Book
2.1 Resources Analysis
The resource basis of GEMS is tremendous as shown in Appendix1, but it is not only the resources themselves that makes the difference, it is the potential it offers to create competitive advantage. The financial resources are stunning, but more important is to what they enables GEMS and why it is able to earn a superior profit margin. The firm’s fantastic and long grown income stream lead to an excellent credit rating and this to a huge and low-priced borrowing capacity. GEMS is investing more than half a billion dollar every year in R&D and has a formidable global presence. The technological sophistication and flexibility of plants and equipment is great and builds the burden for a sufficient working supply chain. The excellent reputation makes it easy for GEMS to attract talents and bind them to the company for a long time.
This composition of resources offers a wide range of possibilities for GEMS. What the organisational capabilities are and how the resources are working together is shown next.
Summary of Chapters
1. Introduction: This chapter introduces GEMS as a leading manufacturer of diagnostic imaging equipment and outlines the scope of the strategic analysis performed.
2. GEMS Competitive Strategy: This section details the resource foundation, core competencies, and the shift from a pure differentiation strategy to a "hybrid" strategy to counter global cost pressures.
3. GEMS International Strategy: This chapter evaluates the company's move toward a transnational strategy and assesses whether specific regional market dynamics, such as those in China, force a shift back to multidomestic elements.
Keywords
General Electric Medical Systems, GEMS, Competitive Strategy, Transnational Strategy, Value Chain Analysis, Resource-Based View, Hybrid Strategy, Globalization, Innovation, Healthcare Market, Cost Leadership, Differentiation, Organizational Learning, Supply Chain Management, Market Responsiveness
Frequently Asked Questions
What is the primary focus of this strategic analysis?
The work focuses on the strategic evaluation of General Electric Medical Systems (GEMS), specifically analyzing its internal resources, competitive positioning, and international strategy framework.
What are the central themes discussed in the document?
Key themes include core competencies, value chain integration, the implementation of a transnational strategy, and the challenge of managing global operations while maintaining local responsiveness.
What is the main objective of the research?
The objective is to understand how GEMS leverages its internal capabilities to maintain a superior profit margin and how it successfully navigates the trade-offs between cost-effectiveness and local market needs.
Which scientific methodology is used for the analysis?
The analysis is grounded in strategic management frameworks, utilizing a resource-based view and value chain analysis to evaluate the company's competitive advantage.
What topics are covered in the main body of the text?
The body covers a detailed assessment of GEMS's competitive strategy, the evolution of its business model toward a "Hybrid Strategy," and an evaluation of its international strategy in global versus local contexts.
Which keywords best characterize this work?
The work is characterized by terms such as GEMS, Transnational Strategy, Hybrid Strategy, Core Competencies, and Global Value Chain.
How does GEMS manage its global value network?
GEMS optimizes its value network by concentrating on high-value "in-house" proprietary technology while outsourcing non-core manufacturing to low-cost countries, integrated through a highly sophisticated global logistics infrastructure.
Why is the "China for China" policy considered a potential threat to GEMS?
The proposed policy would conflict with the company's existing transnational strategy by requiring infrastructure duplication and potentially undermining the efficiency and interdependency gains achieved through its current global organizational model.
- Quote paper
- Marcel Heide (Author), 2006, Harvard Business Review Case Study: General Electric Medical Systems (2002), Munich, GRIN Verlag, https://www.grin.com/document/66137
